411 related articles for article (PubMed ID: 2260623)
1. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
[TBL] [Abstract][Full Text] [Related]
2. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver.
Abdel-Aziz G; Rescan PY; Clement B; Lebeau G; Rissel M; Grimaud JA; Campion JP; Guillouzo A
J Pathol; 1991 Jun; 164(2):167-74. PubMed ID: 2072216
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
5. [Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat].
Marinelli Ibarreta A; Sánchez Movilla A; Izquierdo F; Burgos Lázaro F; Arce Alvarez A; del Castillo-Olivares Ramos JL
Rev Esp Enferm Dig; 1995 Jan; 87(1):25-31. PubMed ID: 7727164
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
Baroni GS; D'Ambrosio L; Curto P; Casini A; Mancini R; Jezequel AM; Benedetti A
Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
[TBL] [Abstract][Full Text] [Related]
8. The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis.
Martinez-Hernandez A
Lab Invest; 1985 Aug; 53(2):166-86. PubMed ID: 3894794
[TBL] [Abstract][Full Text] [Related]
9. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
Ruf G; Mappes HJ; Koch H; Baumgartner U; Hagmann W; Farthmann EH
Hepatogastroenterology; 1996; 43(7):121-6. PubMed ID: 8682446
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
[TBL] [Abstract][Full Text] [Related]
11. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
12. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
13. The effect of ischemia on the regeneration of the cholestatic liver. An experimental study.
Karavias D; Tsamandas AC; Tepetes K; Kritikos N; Kourelis T; Mirra N; Bonikos DS; Androulakis J
Hepatogastroenterology; 2002; 49(44):456-60. PubMed ID: 11995473
[TBL] [Abstract][Full Text] [Related]
14. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy?
Aronson DC; Chamuleau RA; Frederiks WM; Gooszen HG; Heijmans HS; James J
J Hepatol; 1993 Apr; 18(1):85-95. PubMed ID: 8340613
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats.
Takahara T; Furui K; Funaki J; Nakayama Y; Itoh H; Miyabayashi C; Sato H; Seiki M; Ooshima A; Watanabe A
Hepatology; 1995 Mar; 21(3):787-95. PubMed ID: 7875677
[TBL] [Abstract][Full Text] [Related]
18. The extracellular matrix in hepatic regeneration. Localization of collagen types I, III, IV, laminin, and fibronectin.
Martinez-Hernandez A; Delgado FM; Amenta PS
Lab Invest; 1991 Feb; 64(2):157-66. PubMed ID: 1997730
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
Rockey DC; Chung JJ
J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
[TBL] [Abstract][Full Text] [Related]
20. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
